- Home
- CODX vs OCEA Comparison
CODX vs OCEA Comparison
Compare CODX & OCEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CODX
- OCEA
- Stock Information
- Founded
- CODX 2013
- OCEA 2019
- Country
- CODX United States
- OCEA United States
- Employees
- CODX N/A
- OCEA N/A
- Industry
- CODX Medical/Dental Instruments
- OCEA Biotechnology: Pharmaceutical Preparations
- Sector
- CODX Health Care
- OCEA Health Care
- Exchange
- CODX Nasdaq
- OCEA Nasdaq
- Market Cap
- CODX 23.3M
- OCEA 20.5M
- IPO Year
- CODX 2017
- OCEA N/A
- Fundamental
- Price
- CODX $0.83
- OCEA $0.47
- Analyst Decision
- CODX Hold
- OCEA
- Analyst Count
- CODX 1
- OCEA 0
- Target Price
- CODX $1.50
- OCEA N/A
- AVG Volume (30 Days)
- CODX 305.8K
- OCEA 631.6K
- Earning Date
- CODX 03-13-2025
- OCEA 01-13-2025
- Dividend Yield
- CODX N/A
- OCEA N/A
- EPS Growth
- CODX N/A
- OCEA N/A
- EPS
- CODX N/A
- OCEA N/A
- Revenue
- CODX $7,321,012.00
- OCEA N/A
- Revenue This Year
- CODX N/A
- OCEA N/A
- Revenue Next Year
- CODX N/A
- OCEA N/A
- P/E Ratio
- CODX N/A
- OCEA N/A
- Revenue Growth
- CODX 57.16
- OCEA N/A
- 52 Week Low
- CODX $0.67
- OCEA $0.43
- 52 Week High
- CODX $2.23
- OCEA $7.79
- Technical
- Relative Strength Index (RSI)
- CODX 51.48
- OCEA 34.89
- Support Level
- CODX $0.76
- OCEA $0.53
- Resistance Level
- CODX $0.88
- OCEA $0.70
- Average True Range (ATR)
- CODX 0.10
- OCEA 0.08
- MACD
- CODX 0.01
- OCEA -0.02
- Stochastic Oscillator
- CODX 37.17
- OCEA 10.28
About CODX Co-Diagnostics Inc.
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.
About OCEA Ocean Biomedical Inc.
Ocean Biomedical Inc is a biopharmaceutical company that is focused on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases. The company is developing an antibody therapeutic product candidate inhibiting Chi3l1, and a bi-specific antibody product candidate inhibiting Chi3l1 plus PD-1 and CTLA-4 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.